Article Details
Retrieved on: 2022-12-13 21:39:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... our clients' needs and address the changes in the monoclonal antibody market,” said Kasper Møller, Chief Technical Officer of AGC Biologics.
Article found on: www.contractpharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here